Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

Clinical trial NCT00262028 · COMPLETED

Trial details

NCT number: NCT00262028
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prevention of Meningococcal Disease

Start date: 2005-04-01
Primary completion: 2006-11-01
Enrollment: 910

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.